XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Shareholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of change in accounting for credit losses
Common Stock
Capital Surplus
Retained Earnings
Retained Earnings
Cumulative effect of change in accounting for credit losses
Accumulated Other Comprehensive Income, Net of Tax
Treasury Stock
Balance at beginning of period (in shares) at Dec. 31, 2019     71,499,829         1,995,996
Balance at beginning of period at Dec. 31, 2019 $ 2,469,582 $ (56,704) $ 71,500 $ 1,907,108 $ 507,950 $ (56,704) $ 17,995 $ (34,971)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     151,976          
Issuance of restricted shares 289   $ 152 137        
Forfeitures of restricted shares (in shares)     (11,250)          
Forfeitures of restricted shares (170)   $ (11) (159)        
Proceeds from exercise of stock options (in shares)     33,532          
Proceeds from exercise of stock options 701   $ 33 668        
Share-based compensation 2,085     2,085        
Purchase of treasury shares (in shares)               215,309
Purchase of treasury shares (7,973)             $ (7,973)
Net income 51,558       51,558      
Dividends on common stock shares (20,856)       (20,856)      
Other comprehensive income (loss) during the period 21,618           21,618  
Balance at end of period (in shares) at Jun. 30, 2020     71,674,087         2,211,305
Balance at end of period at Jun. 30, 2020 2,460,130   $ 71,674 1,909,839 481,948   39,613 $ (42,944)
Balance at beginning of period (in shares) at Mar. 31, 2020     71,651,986         2,210,712
Balance at beginning of period at Mar. 31, 2020 2,437,150   $ 71,652 1,908,721 460,153   39,551 $ (42,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     33,351          
Issuance of restricted shares 0   $ 33 (33)        
Forfeitures of restricted shares (in shares)     (11,250)          
Forfeitures of restricted shares (170)   $ (11) (159)        
Share-based compensation 1,310     1,310        
Purchase of treasury shares (in shares)               593
Purchase of treasury shares (17)             $ (17)
Net income 32,236       32,236      
Dividends on common stock shares (10,441)       (10,441)      
Other comprehensive income (loss) during the period 62           62  
Balance at end of period (in shares) at Jun. 30, 2020     71,674,087         2,211,305
Balance at end of period at Jun. 30, 2020 2,460,130   $ 71,674 1,909,839 481,948   39,613 $ (42,944)
Balance at beginning of period (in shares) at Dec. 31, 2020     71,753,705         2,212,224
Balance at beginning of period at Dec. 31, 2020 2,647,088   $ 71,754 1,913,285 671,510   33,505 $ (42,966)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     99,308          
Issuance of restricted shares 599   $ 99 500        
Forfeitures of restricted shares (in shares)     (750)          
Forfeitures of restricted shares (20)   $ (1) (19)        
Proceeds from exercise of stock options (in shares)     155,608          
Proceeds from exercise of stock options 4,211   $ 156 4,055        
Share-based compensation 2,745     2,745        
Purchase of treasury shares (in shares)               28,438
Purchase of treasury shares (1,456)             $ (1,456)
Net income 213,289       213,289      
Dividends on common stock shares (20,971)       (20,971)      
Other comprehensive income (loss) during the period (8,481)           (8,481)  
Balance at end of period (in shares) at Jun. 30, 2021     72,007,871         2,240,662
Balance at end of period at Jun. 30, 2021 2,837,004   $ 72,008 1,920,566 863,828   25,024 $ (44,422)
Balance at beginning of period (in shares) at Mar. 31, 2021     71,954,088         2,240,662
Balance at beginning of period at Mar. 31, 2021 2,757,596   $ 71,954 1,917,990 785,984   26,090 $ (44,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of restricted shares (in shares)     13,233          
Issuance of restricted shares 0   $ 13 (13)        
Forfeitures of restricted shares (in shares)     (750)          
Forfeitures of restricted shares (20)   $ (1) (19)        
Proceeds from exercise of stock options (in shares)     41,300          
Proceeds from exercise of stock options 1,209   $ 42 1,167        
Share-based compensation 1,441     1,441        
Purchase of treasury shares 0              
Net income 88,327       88,327      
Dividends on common stock shares (10,483)       (10,483)      
Other comprehensive income (loss) during the period (1,066)           (1,066)  
Balance at end of period (in shares) at Jun. 30, 2021     72,007,871         2,240,662
Balance at end of period at Jun. 30, 2021 $ 2,837,004   $ 72,008 $ 1,920,566 $ 863,828   $ 25,024 $ (44,422)